Glimepiride News
European Medicines Agency: CHMP, Initial Marketing Authorisation Applications, 24-27 April 2006
The Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions on initial marketing authorisation applications for:
Actavis launches Lanzoprazole and Glimepiride
Actavis Group (ICEX: ACT), the international generic pharmaceuticals company, announces that it has launched two medicines, Lanzoprazole and Glimepiride, into the Danish and Finish markets. The products will be sold through the...
Actavis Limited first to Launch generic Glimepiride into EU
Actavis Ltd., located in Bulebel, has launched Glimepiride into a number of EU markets. The launch has been timed to coincide with the expiry of the originator’s patent during the first week of December. The product is an oral...
Mylan Announces Final FDA Approval for Glimepiride Tablets
Pittsburgh, PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA).
Prasco Ships Glimepiride Tablets, the Authorized Generic of Amaryl®; Glimepiride Tablets are AB-Rated to sanofi-aventis' Amaryl; Glimepiride is the First Diabetic Drug in Prasco's Authorized Generic Line
Cincinnati -- Prasco Laboratories, a privately held pharmaceutical company located in Cincinnati, Ohio, announced today it has begun shipping the entire Glimepiride line (1, 2, and 4 mg). Glimepiride is the Authorized Generic of...
Displaying results 11 to 15 out of 15